Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Queval CJ"'
Autor:
Lerner, TR, Queval, CJ, Lai, RP-J, Russell, M, Fearns, A, Greenwood, DJ, Collinson, L, Wilkinson, RJ, Gutierrez, MG
The ability of Mycobacterium tuberculosis to form serpentine cords is intrinsically related to its virulence, but specifically how M. tuberculosis cording contributes to pathogenesis remains obscure. Here, we show that several M. tuberculosis clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::a3edf1046fab84c56671aa2ce5631046
http://hdl.handle.net/10044/1/79490
http://hdl.handle.net/10044/1/79490
Autor:
Proust A; Tuberculosis Laboratory, The Francis Crick Institute, London, NW1 1AT, UK. alize.proust@crick.ac.uk., Queval CJ; High Throughput Screening Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Harvey R; Worldwide Influenza Centre, The Francis Crick Institute, London, NW1 1AT, UK., Adams L; Worldwide Influenza Centre, The Francis Crick Institute, London, NW1 1AT, UK., Bennett M; Worldwide Influenza Centre, The Francis Crick Institute, London, NW1 1AT, UK., Wilkinson RJ; Tuberculosis Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.; Department of Infectious Diseases, Imperial College London, London, W12 0NN, UK.; Institute of Infectious Disease and Molecular Medicine and Department of Medicine, Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Observatory, Cape Town, 7925, Republic of South Africa.
Publikováno v:
Journal of neuroinflammation [J Neuroinflammation] 2023 Aug 03; Vol. 20 (1), pp. 184. Date of Electronic Publication: 2023 Aug 03.
Autor:
Belhaouane I; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France., Pochet A; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France., Chatagnon J; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France., Hoffmann E; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France., Queval CJ; High Throughput Screening Laboratory, The Francis Crick Institute, London, United Kingdom., Deboosère N; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France., Boidin-Wichlacz C; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France., Majlessi L; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université Paris Cité, Paris, France., Sencio V; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France., Heumel S; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France., Vandeputte A; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France., Werkmeister E; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UMS 2014-PLBS, Lille, France., Fievez L; Laboratory of Cellular and Molecular Immunology, GIGA-Research, Liège, Belgium., Bureau F; Laboratory of Cellular and Molecular Immunology, GIGA-Research, Liège, Belgium., Rouillé Y; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France., Trottein F; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France., Chamaillard M; Laboratory of Cell Physiology, INSERM U1003, University of Lille, Lille, France., Brodin P; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France., Machelart A; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2023 Mar 08; Vol. 19 (3), pp. e1011192. Date of Electronic Publication: 2023 Mar 08 (Print Publication: 2023).
Autor:
Fendler A; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Shepherd STC; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Au L; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Wu M; COVID Surveillance Unit, The Francis Crick Institute, London NW1 1AT, UK., Harvey R; Worldwide Influenza Centre, The Francis Crick Institute, London NW1 1AT, UK., Wilkinson KA; Tuberculosis Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Wellcome Center for Infectious Disease Research in Africa, University of Cape Town, Observatory 7925, Republic of South Africa., Schmitt AM; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Tippu Z; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Shum B; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Farag S; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Rogiers A; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Carlyle E; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Edmonds K; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Del Rosario L; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Lingard K; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Mangwende M; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Holt L; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Ahmod H; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Korteweg J; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Foley T; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Barber T; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Emslie-Henry A; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Caulfield-Lynch N; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Byrne F; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Deng D; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Kjaer S; Structural Biology Scientific Technology Platform, The Francis Crick Institute, London NW1 1AT, UK., Song OR; High Throughput Screening Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Queval CJ; High Throughput Screening Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Kavanagh C; COVID Surveillance Unit, The Francis Crick Institute, London NW1 1AT, UK., Wall EC; High Throughput Screening Laboratory, The Francis Crick Institute, London NW1 1AT, UK; University College London Hospitals NHS Foundation Trust Biomedical Research Centre, London WC1E 6BT, UK., Carr EJ; Cell Biology of Infection Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Caidan S; Safety, Health & Sustainability, The Francis Crick Institute, London NW1 1AT, UK., Gavrielides M; Scientific Computing Scientific Technology Platform, The Francis Crick Institute, London NW1 1AT, UK., MacRae JI; Metabolomics Scientific Technology Platform, The Francis Crick Institute, London NW1 1AT, UK., Kelly G; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK., Peat K; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Kelly D; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Murra A; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Kelly K; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., O'Flaherty M; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Shea RL; Department of Pathology, The Royal Marsden NHS Foundation Trust, London NW1 1AT, UK; Translational Cancer Biochemistry Laboratory, The Institute of Cancer Research, London SW7 3RP, UK., Gardner G; Department of Pathology, The Royal Marsden NHS Foundation Trust, London NW1 1AT, UK., Murray D; Department of Pathology, The Royal Marsden NHS Foundation Trust, London NW1 1AT, UK., Popat S; Lung Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Yousaf N; Lung Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK; Acute Oncology Service, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Jhanji S; Anaesthetics, Perioperative Medicine and Pain Department, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Tatham K; Anaesthetics, Perioperative Medicine and Pain Department, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Cunningham D; Gastrointestinal Unit, The Royal Marsden NHS Foundation Trust, Sutton SM2 5PT, UK., Van As N; Clincal Oncology Unit, The Royal Marsden NHS Foundation Trust, London NW1 1AT, UK., Young K; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Furness AJS; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Pickering L; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Beale R; Cell Biology of Infection Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Division of Medicine, University College London, London NW1 2PG, UK., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, UK; University College London Cancer Institute, London WC1E 6DD, UK., Gandhi S; Neurodegeneration Biology Laboratory, The Francis Crick Institute, London NW1 1AT, UK; UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK., Gamblin S; Structural Biology of Disease Processes Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Bauer DLV; RNA Virus Replication Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Kassiotis G; Retroviral Immunology Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Howell M; High Throughput Screening Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Nicholson E; Haemato-oncology Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK; Haemato-oncology Unit, The Institute of Cancer Research, London SW7 3RP, UK., Walker S; Anaesthetics, Perioperative Medicine and Pain Department, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Wilkinson RJ; Tuberculosis Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Wellcome Center for Infectious Disease Research in Africa, University of Cape Town, Observatory 7925, Republic of South Africa; Department of Infectious Disease, Imperial College London, London W2 0NN, UK., Larkin J; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK; Melanoma and Kidney Cancer Team, The Institute of Cancer Research, London SW7 3RP, UK., Turajlic S; Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK; Melanoma and Kidney Cancer Team, The Institute of Cancer Research, London SW7 3RP, UK. Electronic address: samra.turajlic@crick.ac.uk.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2022 Oct 18; Vol. 3 (10), pp. 100781. Date of Electronic Publication: 2022 Sep 27.
Autor:
Blanco FC; CICVyA, Institute of Biotechnology, National Institute of Agricultural Technology (INTA), Buenos Aires, Argentina., Queval CJ; HTS, Francis Crick Institute, London, United Kingdom., Araujo FR; Brazilian Agricultural Research Corporation (EMBRAPA), Brasília, Brazil., De Waard JH; One Health Research Group, Facultad de Ciencias Veterinarias, Universidad de Las Américas, Quito, Ecuador.
Publikováno v:
Frontiers in veterinary science [Front Vet Sci] 2022 Apr 26; Vol. 9, pp. 907353. Date of Electronic Publication: 2022 Apr 26 (Print Publication: 2022).
Autor:
Wu M; The Francis Crick Institute, London NW1 1AT, UK., Wall EC; The Francis Crick Institute, London NW1 1AT, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK., Carr EJ; The Francis Crick Institute, London NW1 1AT, UK., Harvey R; Worldwide Influenza Centre, The Francis Crick Institute, London, UK., Townsley H; The Francis Crick Institute, London NW1 1AT, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK., Mears HV; The Francis Crick Institute, London NW1 1AT, UK., Adams L; Worldwide Influenza Centre, The Francis Crick Institute, London, UK., Kjaer S; The Francis Crick Institute, London NW1 1AT, UK., Kelly G; The Francis Crick Institute, London NW1 1AT, UK., Warchal S; The Francis Crick Institute, London NW1 1AT, UK., Sawyer C; The Francis Crick Institute, London NW1 1AT, UK., Kavanagh C; The Francis Crick Institute, London NW1 1AT, UK., Queval CJ; The Francis Crick Institute, London NW1 1AT, UK., Ngai Y; University College London, London, UK., Hatipoglu E; University College London, London, UK., Ambrose K; The Francis Crick Institute, London NW1 1AT, UK., Hindmarsh S; The Francis Crick Institute, London NW1 1AT, UK., Beale R; The Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK., Gamblin S; The Francis Crick Institute, London NW1 1AT, UK., Howell M; The Francis Crick Institute, London NW1 1AT, UK., Kassiotis G; The Francis Crick Institute, London NW1 1AT, UK; Department of Infectious Disease, St Mary's Hospital, Imperial College London, London, UK., Libri V; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK., Williams B; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK., Gandhi S; The Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK., Swanton C; The Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK., Bauer DL; The Francis Crick Institute, London NW1 1AT, UK. Electronic address: david.bauer@crick.ac.uk.
Publikováno v:
Lancet (London, England) [Lancet] 2022 Feb 19; Vol. 399 (10326), pp. 715-717. Date of Electronic Publication: 2022 Jan 19.
Autor:
Queval CJ; The Francis Crick Institute, London, United Kingdom., Fearns A; The Francis Crick Institute, London, United Kingdom., Botella L; The Francis Crick Institute, London, United Kingdom., Smyth A; UCD School of Veterinary Medicine and UCD Conway Institute, University College Dublin, Dublin, Ireland., Schnettger L; The Francis Crick Institute, London, United Kingdom., Mitermite M; UCD School of Veterinary Medicine and UCD Conway Institute, University College Dublin, Dublin, Ireland., Wooff E; Animal and Plant Health Agency, Addlestone, United Kingdom., Villarreal-Ramos B; Animal and Plant Health Agency, Addlestone, United Kingdom.; Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, Aberystwyth, United Kingdom., Garcia-Jimenez W; Department of Pathology an Infectious Diseases. School of Veterinary Medicine. University of Surrey, Guildford, United Kingdom., Heunis T; Biosciences Institute, Newcastle University, Newcastle, United Kingdom., Trost M; Biosciences Institute, Newcastle University, Newcastle, United Kingdom., Werling D; Department of Pathobiology and Population Sciences, The Royal Veterinary College, University of London, Hatfield Hertfordshire, United Kingdom., Salguero FJ; Department of Pathology an Infectious Diseases. School of Veterinary Medicine. University of Surrey, Guildford, United Kingdom.; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, United Kingdom., Gordon SV; UCD School of Veterinary Medicine and UCD Conway Institute, University College Dublin, Dublin, Ireland., Gutierrez MG; The Francis Crick Institute, London, United Kingdom.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2021 Mar 15; Vol. 17 (3), pp. e1009410. Date of Electronic Publication: 2021 Mar 15 (Print Publication: 2021).
Autor:
Lerner TR; Host-pathogen interactions in tuberculosis laboratory., Queval CJ; Host-pathogen interactions in tuberculosis laboratory., Lai RP; Tuberculosis laboratory, and., Russell MR; Electron Microscopy Scientific Technology Platform, The Francis Crick Institute, London, United Kingdom., Fearns A; Host-pathogen interactions in tuberculosis laboratory., Greenwood DJ; Host-pathogen interactions in tuberculosis laboratory., Collinson L; Electron Microscopy Scientific Technology Platform, The Francis Crick Institute, London, United Kingdom., Wilkinson RJ; Tuberculosis laboratory, and.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, and Department of Medicine, University of Cape Town, Cape Town, Republic of South Africa.; Department of Medicine, Imperial College London, London, United Kingdom., Gutierrez MG; Host-pathogen interactions in tuberculosis laboratory.
Publikováno v:
JCI insight [JCI Insight] 2020 May 21; Vol. 5 (10). Date of Electronic Publication: 2020 May 21.
Autor:
Patterson KC; Brighton and Sussex Medical School, 94N-SRd, Falmer, Brighton, BN1 9PX, UK.; Host-Pathogen Interactions in Tuberculosis Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Queval CJ; Host-Pathogen Interactions in Tuberculosis Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Gutierrez MG; Host-Pathogen Interactions in Tuberculosis Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Publikováno v:
BioEssays : news and reviews in molecular, cellular and developmental biology [Bioessays] 2019 Nov; Vol. 41 (11), pp. e1900086. Date of Electronic Publication: 2019 Oct 07.
Autor:
Costa-Gouveia J; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Pancani E; University of Paris-Sud, University Paris-Saclay, CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO), 91405, Orsay, France., Jouny S; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Machelart A; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Delorme V; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Salzano G; University of Paris-Sud, University Paris-Saclay, CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO), 91405, Orsay, France., Iantomasi R; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Piveteau C; Univ. Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000, Lille, France., Queval CJ; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Song OR; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Flipo M; Univ. Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000, Lille, France., Deprez B; Univ. Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000, Lille, France., Saint-André JP; University Hospital Center of Angers, 49000, Angers, France., Hureaux J; University Hospital Center of Angers, 49000, Angers, France., Majlessi L; Pathogénomique Mycobactérienne Intégrée, Département de Génomes et Génétique, Institut Pasteur, Paris, France., Willand N; Univ. Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000, Lille, France., Baulard A; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Brodin P; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France. priscille.brodin@inserm.fr., Gref R; University of Paris-Sud, University Paris-Saclay, CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO), 91405, Orsay, France. ruxandra.gref@u-psud.fr.
Publikováno v:
Scientific reports [Sci Rep] 2018 May 10; Vol. 8 (1), pp. 7596. Date of Electronic Publication: 2018 May 10.